1. Home
  2. CRI vs XNCR Comparison

CRI vs XNCR Comparison

Compare CRI & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$31.77

Market Cap

1.2B

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$15.85

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
XNCR
Founded
1865
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2003
2013

Fundamental Metrics

Financial Performance
Metric
CRI
XNCR
Price
$31.77
$15.85
Analyst Decision
Sell
Buy
Analyst Count
5
10
Target Price
$28.80
$22.78
AVG Volume (30 Days)
1.1M
840.9K
Earning Date
10-27-2025
11-05-2025
Dividend Yield
3.13%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$2,832,687,000.00
$150,132,000.00
Revenue This Year
$1.58
$18.81
Revenue Next Year
$0.14
N/A
P/E Ratio
$13.03
N/A
Revenue Growth
N/A
38.16
52 Week Low
$23.38
$6.92
52 Week High
$56.89
$25.02

Technical Indicators

Market Signals
Indicator
CRI
XNCR
Relative Strength Index (RSI) 48.97 48.75
Support Level $31.80 $16.44
Resistance Level $33.38 $17.18
Average True Range (ATR) 1.25 0.94
MACD -0.06 -0.29
Stochastic Oscillator 18.73 17.99

Price Performance

Historical Comparison
CRI
XNCR

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: